Pricing Log in Create free account

Decoy Therapeutics Inc (DCOY) vs Jupiter Neurosciences, Inc. (JUNS)

Decoy Therapeutics Inc and Jupiter Neurosciences, Inc. are both Biotechnology companies. Decoy Therapeutics Inc and Jupiter Neurosciences, Inc. are of similar size ($2.8M and $2.7M). Jupiter Neurosciences, Inc. has the higher net margin (0.00% vs −698.8%) and the higher return on invested capital (0.00% vs 0.00%). Across the 11 metrics below, Jupiter Neurosciences, Inc. leads on 8 and Decoy Therapeutics Inc on 3.

Valuation

Metric DCOY JUNS Biotechnology median
P/E n/m n/m 10.60
P/S 0.29 n/m 9.40
P/B 0.14 n/m 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 0.49 0.01 0.66
EV/Sales (3.49) n/m 9.02
Earnings yield (5,122.62%) (842.19%) (32.88%)
Free cash flow yield (1,736.93%) (572.73%) (23.13%)

Profitability

Metric DCOY JUNS Biotechnology median
Gross margin 10.57% — 68.51%
Operating margin (706.88%) 0.00% 0.00%
Net margin (698.79%) 0.00% 0.00%
Free cash flow margin (432.43%) 0.00% 0.00%
Return on equity (827.77%) (1,888.80%) (51.96%)
Return on assets (278.04%) (239.36%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric DCOY JUNS Biotechnology median
Revenue growth (TTM) (60.49%) — 6.76%
EPS growth (last fiscal year) 87.62% (212.50%) 29.88%
Revenue growth, 5-year CAGR 12.73% — 9.75%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric DCOY JUNS Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 1.83 0.66 4.97
Net debt to EBITDA 0.85 0.43 1.01

Dividend

Metric DCOY JUNS Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric DCOY JUNS Biotechnology median
Market cap 2.67m 2.81m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack